#ESCCongress – [Abstract Only] Randomized Trial: PCI vs. CABG in Patients with Three-vessel or Left Main Coronary Artery Disease

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial – The Lancet (link to abstract – $ for full-text)

Commentary: Bypass surgery and coronary stenting yield comparable 10-year survival – European Society of Cardiology (free)

Related Meta-Analysis: Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease (link to abstract) AND Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis (free)

Related Commentary on Twitter

SYNTAX extended survival: 10yr all cause death PCI vs CABG:

❤️no significant difference in all cause death (24%CABG/27%PCI)
❤️CABG better than PCI for 3VD (21%CABG/28%PCI)
❤️no significant difference in LMS disease

Impressive 94% FU.https://t.co/X4g9WgTBXI#ESCCongress pic.twitter.com/M7halGNnsv

— Sarah Hudson (@sarahhudsonuk) September 2, 2019